Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer

Journal of Clinical Oncology

Volumn 16, Issue 11, 1998, Pages 3662-3673

  Sloan, Jeff A ^a   Loprinzi, Charles L ^a   Kuross, Steven A ^a   Miser, Angela W ^a   O'Fallon, Judith R ^a   Mahoney, Michelle R ^a   Heid, Iris M ^a   Bretscher, Mary E ^a   Vaught, Nancy L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE;

EID: 0031734759     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.11.3662     Document Type: Article

References (95)

1. Klausner RD, Hubbard SM, Chappell J: Quality of life in clinical cancer trials. J NCI Monog 20, 1996
2. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671-679, 1996
3. Beardsley T: A war not won. Sci Am: 130-138, 1994
4. Tannock IF: Treating the patient, not just the cancer. N Engl J Med 317:1534-1535, 1987
5. Beitz J, Gnecco C, Justice R: Quality of life endpoints in cancer clinical trials: The U.S. Food and Drug Administration perspective. JNCI Monogr 20:7-9, 1996
6. Cella DF: Quality of life outcomes: Measurement and validation. Oncology 10:233-244, 1996
7. Cella DF: Measuring quality of life: 1995 update. Oncology 9:47-60, 1995
8. Aaronson NK, Meyerowitz BE, Bard M, et al: Quality of life research in oncology. Cancer 67:839-843, 1991 (suppl)
9. Smith ND: Quality of life studies from the perspective of an FDA reviewing statistician. Drug Inform J 27:617-623, 1993
10. Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials. (ed 2). New York, NY, Raven, 1996
11. Treasure T, Gallivan S: Quality of life data: How can we get best quality from them? J R Soc Med 88:125-126, 1995
12. Aaronson NK: Methodological issues in assessing the quality of life of cancer patients. Cancer 67:844-850, 1991
13. Cella DF: Quality of life: concepts and definitions. J Pain Sympt Manage 9:186-192, 1994
14. Osoba D: Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12:608-616, 1994
15. Moinpour CM: Measuring quality of life: An emerging science. Semin Oncol 21:48-60, 1994
16. Cella DF, Bonomi AE: Measuring quality of life: 1995 update. Oncology 9:47-60, 1995 (suppl)
17. McCarthy DM: Quality of life: A critical assessment. Scand J Gastroenterol 30:141-146, 1995
18. Cella DF, Tulsky DS, Gray G, et al: The functional assessment of cancer therapy (FACT) scale: Development and validation of the general version. J Clin Oncol 11:570-579, 1993
19. Osoba D, Zee B, Wan D, et al: Psychometric properties and responsiveness of the EORTC quality of life questionnaire (QLQ-30) in patients with breast, ovarian and lung cancer. Qual Life Res 3:143-154, 1994
20. McHorney CA: Measuring and monitoring general health status in elderly persons: Practical and methodological issues in using the SF-36 health survey. Gerontologist 36:571-583, 1996
21. Gonin R, Lloyd S, Cella D: Establishing equivalence between scaled measures of quality of life. Qual Life Res 5:20-26, 1996
22. Wilson IB, Cleary PD: Linking clinical variables with health-related quality of life. JAMA 273:59-64, 1995
23. Stewart AL: Conceptual and methodologic issues in defining quality of life: State of the art. Prog Cardiovasc Nurs 7:3-11, 1992
24. Cella DF, Tulsky DS: Measuring quality of life today: methodological aspects. Oncology 4:29-38, 1990
25. Geddes DM: Quality of life in lung cancer. Resp Med 85:7-11, 1991 (suppl B)
26. Bleehen NM, Girling DJ, Machin D, et al: A randomized trial of three or six courses of etoposide, cyclophosphamide, methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party. Br J Cancer 68:1157-1166, 1993
27. Hopwood P, Stephens RJ, Mochin D: Approaches to the analysis of quality of life data: Experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 3:339-352, 1994
28. Cella DF: Measuring quality of life in palliative care. Semin Oncol 22:73-78, 1995 (suppl 3)
29. Loprinzi CL, Goldberg RM, Su JQ, et al: Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol 12:1126-1129, 1994
30. Spitzer W, Dobson AJ, Hall J, et al: Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chronic Dis 34:585-597, 1981
31. Schipper H, Clinch J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. J Clin Oncol 2:472-483, 1986
32. Pocock SL, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115, 1975
33. Ringdal GI, Ringdal K, Kvinnsland S, et al: Quality of life of cancer patients with different prognoses. Qual Life Res 3:143-154, 1994
34. Ahmedazi S: Measuring quality of life in hospice care. in Tchekmedyaib NS, Cella DF (eds): Quality of Life in Oncology Practice and Research. Williston Park, NY, Dominus, 1991, pp 27-54
35. Bullinger M: Quality of life assessment in palliative care. J Palliat Care 8:34-39, 1992
36. Gough IR, Furnival CM, Schilder L, et al: Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 19:1161-1165, 1983
37. Ventafridda V, DeConno F, Ripamonti C, et al: Quality of life assessment during a palliative care programme. Ann Oncol 1:415-420, 1990
38. Giorgi F, Cellerino R, Gramazio A, et al: Assessing quality of life in patients with cancer: A comparison of a visual-analogue and a categorical model. Am J Clin Oncol 19:394-399, 1996
39. Dudgeon D, Clinch J: A longitudinal study of needs and quality of life (QOL) in advanced cancer patients. Proc Am Soc Clin Oncol 13:A1505, 1994 (abstr)
40. Clinch JJ: The Functional Living Index-Cancer: Ten years later. in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials (ed 2). New York, NY, Lippincott-Raven, 1996, pp 215-226
41. Morrow GR, Lindke J, Black P: Measurement of quality of life in patients: Psychometric analyses of the Functional Living Index Cancer (FLIC). Qual Life Res 1:287-296, 1992
42. Schag CAC, Ganz PA, Heinrich RL: Cancer Rehabilitation Evaluation System-Short Form (CARES-SF): A cancer specific rehabilitation and quality of life instrument. Cancer 68:1406-1413, 1991
43. Portenoy RK, Kornblith AB, Wong G, et al: Pain in ovarian cancer patients: Prevalence, characteristics, and associated symptoms. Cancer 74:907-915, 1994
44. Ganz PA, Schag CAC, Lee J, et al: Breast conservation versus mastectomy: Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729-1738, 1992
45. Kornblith AB, Hollis DR, Zuckerman E, et al: Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. J Clin Oncol 11:2081-2089, 1993
46. Andrykowski MA, Henslee PJ, Barnett RL: Longitudinal assessment of psychosocial functionining of adult supervisors of allogeneic bone marrow transplantation. Bone Marrow Transplant 4:505-509, 1989
47. Andrykowski MA, Altmaier EM, Barnett RL, et al: The quality of life in adult survivors of allogeneic bone marrow transplantation: Correlates and comparison with matched renal transplant recipients. Transplantation 50:399-406, 1990
48. Peters WP, Ross M, Vrendenburgh JJ, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132-1143, 1993
49. Cassileth BR, Soloway MS, Vogelzang NJ, et al: Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. Qual Life Res 1:323-329, 1992
50. Finkelstein DM, Cassileth BR, Bonomi PD, et al: A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. Am J Clin Oncol (CCT) 11:630-633, 1988
51. Perez DJ, McGee R, Campbell AV, et al: A comparison of time trade-off and quality of life measures in patients with advanced cancer. Qual Life Res 6:133-138, 1997
52. Cohen SR, Mount BM, Bruera E, et al: Validity of the McGill Quality of Life Questionnaire in the palliative care setting: A multicentre Canadian study demonstrating the importance of the existential domain. Palliat Med 11:3-20, 1997
53. Gaston-Johansson E, Foxall M: Psychological correlates of quality of life across the autologous bone marrow transplant experience. Cancer Nurs 19:170-176, 1996
54. Weitzner MA, Meyers CA, Gelke CK, et al: The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151-1161, 1995
55. Johnson DJ, Casey L, Noriega B: A pilot study of patient quality of life during radiation therapy treatment. Qual Life Res 3:267-272, 1994
56. Youngblood M, Williams PD, Eyles H, et al: A comparison of two methods of assessing cancer therapy-related symptoms. Cancer Nurs 17:37-44, 1994
57. Dales RE, Dionne G, Leech JA, et al: Preoperative prediction of pulmonary complications following thoracic surgery. Chest 104:155-159, 1993
58. Coates A, Gebski V, Signorini D, et al: Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 10:1833-1838, 1992
59. Loizou LA, Rampton D, Atkinson M, et al: A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 70:386-391, 1992
60. Kuttner L, LePage T: Face scales for the assessment of pediatric pain: A critical review. Can J Behav Sci 21:198-209, 1989
61. McDowell I, Newell C: Measuring Health. New York, NY, Oxford University, 1996, pp 194-198
62. Lehman AF, Ward NC, Linn LS: Chronic mental patients: The quality of life issue. Am J Psychiatry 139:1271-1276, 1982
63. McGrath PA, de Veber LL, Hearn MT: Multidimensional pain assessment in children, in Fields HL, Dubner R, Cervero F (eds): Advances in Pain Research and Therapy, vol 9. New York, NY, Raven, 1985, pp 387-393
64. Beckie TM, Hayduk LA: Measuring quality of life. Soc Indicat Res 42:21-39, 1997
65. Hamalainen ML, Hoppu K, Santavuori P: Pain and disability in migraine or other recurrent headaches as reported by children. Eur J Neurol 3:528-532, 1996
66. Bachiocco V, Gentili A, Bortoluzzi L: β-endorphin and "overt" pain measures in children. J Pain Sympt Manage 10:1-3, 1995
67. Pound P, Gompertz P, Ebrahim S: Development and results of a questionnaire to measure career satisfaction after stroke. J Epidemiol Commun Health 47:500-505, 1993
68. Harrison A: Comparing nurses' and patients' pain evaluations: A study of hospitalized patients in Kuwait. Soc Sci Med 36:683-692, 1993
69. Belter RW, McIntosh JA, Finch AJ, et al: Preschoolers' ability to differentiate levels of pain: Relative efficacy of three self-report measures. J Clin Child Psychol 17:329-335, 1988
70. Staats SR, Stassen MA: Age and present and future perceived quality of life. Int J Aging Hum Dev 25:167-176, 1987
71. Bland JM, Altman DG: Comparing two methods of clinical measurement: A personal history. Int J Epidemiol 24:S7-S14, 1995 (suppl)
72. Poon MA, O'Connell MJ, Moertel CG, et al: Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal cancer. J Clin Oncol 7:1407-1418, 1989
73. Jaeschke R, Singer J, Guyatt GH: Measurement of health status. Ascertaining the minimally clinically significant difference. Control Clin Trials 10:407-415, 1989
74. Jacobson NS, Truax P: Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59:12-19, 1991
75. Cohen J: Statistical Power Analysis for the Behavioral Sciences (ed 2). Hillsdale, NJ, Erlbaum, 1988
76. Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrika 52:591-610, 1965
77. Hurny C, Bernhard J, Joss R, et al: Feasibility of QOL assessment in a randomized phase III trial of small cell lung cancer - A lesson from the real world. Ann Oncol 3:825-831, 1992
78. McMillan SC, Mahon M: A study of quality of life of hospice patients on admission and at week 3. Cancer Nurs 17:52-60, 1994
79. Presant CA: Quality of life in cancer patients. Who measures what? Am J Clin Oncol 7:571-573, 1984
80. Slevin ML, Plant H, Lynch D, et al: Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109-112, 1988
81. Kahn SB, Houts PS, Harding SP: Quality of life and patients with cancer: A comparative study of patient versus physician perceptions and its implications for cancer education. J Cancer Educ 7:241-249, 1992
82. Sneeuw KC, Aaronson NK, Sprangers MA, et al: Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol 15:1206-1217, 1997
83. Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144, 1998
84. Redelmeier DA, Guyatt GH, Goldstein RS: Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 49:1215-1219, 1996
85. Naylor CD, Llewellyn-Thomas HA: Can there be a more patient-centered approach to determining clinically important effect sizes for randomized treatment trials? J Clin Epidemiol 47:787-795, 1994
86. Lydick E, Yawn BP: Clinical interpretation of health-related quality of life data, in Staquet MJ, Hays RD, Fayers PM (eds): Quality of Life Assessment in Clinical Trials. New York, NY, Oxford University, New York, 1998, pp 299-314
87. Juniper EF, Guyatt GH, Willan A, et al: Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 47:81-87, 1994
88. Jaeschke RJ: Ascertaining the minimal clinically important difference. Control Clin Trials 10:407-415, 1989
89. Sloan JA, O'Fallon JR, Suman VJ, et al: Incorporating QOL measurement in oncology clinical trials. Proc Am Stat Assoc, pp 282-287, 1997
90. Barofsky I, Erickson P, Eberhardt M: Comparison of multiattribute and self-assessed health status measures among persons with and without diabetes in the US general population. Drug Information Association Workshop on Quality of Life Measurement, Charleston, SC, May 1997
91. Krause NM, Jay GM: What do global self-rated health items measure? Med Care 32:930-942, 1994
92. Kornblith AB, Herr HW, Ofman US, et al: Quality of life ofpatients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer 73:2791-2802, 1994
93. Gough IR, Furnival CM, Schilder L, et al: Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 19:1161-1165, 1983
94. Aaronson NK, Ahmedzia S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 85:365-376, 1993
95. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993